Fusion Versus Excision of the Symptomatic Type II Accessory Navicular: A Prospective Study

2009 ◽  
Vol 30 (1) ◽  
pp. 10-15 ◽  
Author(s):  
Aaron T. Scott ◽  
Vani J. Sabesan ◽  
Jonathan R. Saluta ◽  
Melanie A. Wilson ◽  
Mark E. Easley
Keyword(s):  
Prospective Study ◽  
Type Ii ◽  
Accessory Navicular ◽  
A Prospective Study

scholarly journals Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands

2013 ◽  
Vol 109 (11) ◽  
pp. 2924-2932 ◽  
Author(s):  
P Eijgenraam ◽  
M M Heinen ◽  
B A J Verhage ◽  
Y C Keulemans ◽  
L J Schouten ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Risk ◽  
The Netherlands ◽  
Prospective Study ◽  
Diabetes Type ◽  
Type Ii ◽  
Medical Conditions ◽  
Pancreatic Cancer Risk ◽  
Diabetes Type Ii ◽  
A Prospective Study

Giant Cell Tumours of Tendon Sheath: Classification and Recurrence Rate

2001 ◽  
Vol 26 (1) ◽  
pp. 72-75 ◽  
Author(s):  
M. M. AL-QATTAN
Keyword(s):  
Prospective Study ◽  
Giant Cell ◽  
Giant Cell Tumour ◽  
Tendon Sheath ◽  
Type I ◽  
Type Ii ◽  
Giant Cell Tumours ◽  
The Mean ◽  
A Prospective Study

Forty-three consecutive cases of giant cell tumour of tendon sheath were included in a prospective study. The tumours were classified into two main types, depending on whether the entire tumour was, or was not, surrounded by one pseudocapsule as assessed by the surgeon during surgery. Each type was then sub-classified according to the thickness of the capsule, lobulation of the tumour, the presence of satellite lesions, and the diffuse or multicenteric nature of the tumour: these factors were also assessed by the surgeon. The mean follow-up period was 4 (range, 2–6) years. None of the type I tumours ( n=30) recurred, but recurrence occurred in five out of 13 type II tumours. Second recurrences were seen with type II B and C, but not type II A tumours.

scholarly journals A Prospective Study of Clinical Factors (BMI, DM) Influencing Healing of Abdominal Incisions Correlated with Tissue Expression of MMP2, MMP9 and TIMP

2020 ◽  
Vol 3 (1) ◽  
pp. 142-148
Author(s):  
Venkat Vaijnath Cholleti ◽  
Mohd. Ilyas
Keyword(s):  
Wound Healing ◽  
Growth Factors ◽  
Prospective Study ◽  
Tissue Expression ◽  
Obese Patients ◽  
Type Ii ◽  
Clinical Factors ◽  
Extracellular Proteases ◽  
Surgical Wounds ◽  
A Prospective Study

Background: There is a dynamic and reciprocal interaction among ECM and involving cells, cytokines, growth factors and proteases (MMP/TIMP). The controlled degradation of ECM by extracellular proteases particularly MMP/TIMP and serene proteases forms the basis of wound healing. To study clinical factors (BMI, DM) influencing healing of acute abdominal surgical wounds as graded by tissue expression of MMP 2, MMP 9 and TIMP. Subjects and Methods: The present study was conducted in 46 patients in the Department of General Surgery, Kamineni Hospitals, L.B. Nagar, Hyderabad. Results: Type II DM was found in 63 % of patients and found to be having significantly affecting wound healing (p = 0.0017). Wound healing was delayed in uncontrolled DM. Diabetics with healed wound had increased expression of MMP-2 and decreased expression of MMP-9 while Diabetics with non-healed had strong expression of MMP-9 and TIMP as compared to MMP-2. Obesity was seen in 47.82 % of patients and significantly affected wound healing (p = 0.0022). Obese patients with healed wounds had increased expression of MMP-2 and MMP – 9 with decreased TIMP levels. Conclusion: The present study strongly supported tissue expression of MMP-2, MMP-9 and TIMP 2 balance between 7-14 days as a good predictor of wound healing in abdominal laprotomy wounds.

Sign in / Sign up

Export Citation Format

Share Document